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ABSTRACT 
Joubert syndrome (JS) is a recessive, neurodevelopmental disorder characterized by hypotonia, ataxia, 
abnormal eye movements and variable cognitive impairment. It is defined by a distinctive brain malformation 
recognized as the "molar tooth sign" on axial MRI. Subsets of affected individuals have malformations such as 
coloboma, polydactyly, and encephalocele, as well as progressive retinal dystrophy, fibrocystic kidney disease 
and liver fibrosis. More than 35 genes have been associated with JS, but the genetic cause remains unknown 
in a subset of families. All of the gene products localize in and around the primary cilium, making JS a 
canonical ciliopathy. Ciliopathies are unified by their overlapping clinical features and underlying mechanisms 
involving ciliary dysfunction. In this work, we identify biallelic rare, predicted-deleterious ARMC9 variants (stop-
gain, missense, splice-site, and single exon deletion) in 11 individuals with JS from 8 families, accounting for 
approximately 1% of the disorder. The associated phenotypes range from isolated neurological involvement, to 
JS with retinal dystrophy, additional brain abnormalities (e.g. heterotopia, Dandy-Walker malformation), 
pituitary insufficiency, and/or synpolydactyly. We show that ARMC9 localizes to the basal body of the cilium 
and is upregulated during ciliogenesis. Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, 
coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional 
support for ARMC9 as a ciliopathy associated gene. Identifying ARMC9 mutations as a cause of JS takes us 
one step closer to a full genetic understanding of this important disorder and enables future functional work to 
define the central biological mechanisms underlying JS and other ciliopathies. 
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INTRODUCTION 
Joubert syndrome (JS OMIM: P213330) is a recessive neurodevelopmental disorder characterized by 
motor and cognitive impairments and a distinctive hindbrain malformation giving the appearance of the “molar 
tooth sign” (MTS) on axial MRI. In addition to the obligate neurological features, subsets of individuals with JS 
have progressive retinal dystrophy, fibrocystic kidney disease and liver fibrosis, as well as malformations such 
as chorioretinal coloboma and polydactyly. Despite this distinctive clinical presentation, mutations in more than 
35 genes cause JS, highlighting its marked genetic heterogeneity.1-24 All of the genes to date encode proteins 
that function in or around the primary cilium, rendering JS a canonical ciliopathy; ciliopathies are disorders 
grouped by their overlapping clinical features and molecular disease mechanisms involving cilium 
dysfunction.24-27 The primary cilium is a nearly ubiquitous microtubule-based organelle sheathed in a 
specialized membrane that projects from the cellular surface and functions like an antenna, detecting light, 
mechanical, and chemical cues, as well as regulating key signaling pathways such as Hedgehog 28-34 and 
PDGF. 35; 36 Significant advances have been made in recent years on the complex genetics underlying JS, and 
multiple cellular and developmental defects have been associated with loss of function for JS-associated 
genes in model systems.11; 22; 31; 37-45 Despite this remarkable progress identifying candidate mechanisms, the 
common cellular dysfunction across genetic causes of JS is elusive. Therefore it is essential to identify the 
complete set of genetic defects that underlie JS to pinpoint the unifying molecular mechanism. In this work, we 
present evidence for mutations in armadillo repeat containing 9 (ARMC9) as a cause of JS, based on human 
genetic, protein localization, and zebrafish model data. 
 
MATERIALS AND METHODS 
Subject ascertainment and phenotypic data 
Informed consent was obtained for all participants under approved human subjects research protocols at the 
University of Washington (UW), Seattle Children’s Hospital, or King Faisal Specialist Hospital and Research 
Centre (KFSHRC). All participants have clinical findings of JS (intellectual impairment, hypotonia, ataxia and/or 
oculomotor apraxia) and diagnostic or supportive brain imaging findings (MTS or cerebellar vermis hypoplasia). 
Clinical data were obtained by direct examination of participants, review of medical records and structured 
questionnaires. 
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Variant identification 
Samples from individuals affected by JS were previously screened using a Molecular Inversion Probes (MIPs) 
targeted capture46 for AHI1 [OMIM: 608894], ARL13B [OMIM: 608922], B9D1 [OMIM: 614144], B9D2 [OMIM: 
611951], C2CD3 [OMIM: 615944], C5ORF42 [OMIM: 614571], CC2D2A [OMIM: 612013], CEP290 [OMIM: 
61042], CEP41 [OMIM: 610523], CSPP1 [OMIM: 611654], IFT172 [OMIM: 607386], INPP5E [OMIM: 613037], 
KIF7 [OMIM: 611254], MKS1 [OMIM: 609883], NPHP1 [OMIM: 607100], OFD1 [OMIM: 300170], RPGRIP1L 
[OMIM: 610937], TCTN1 [OMIM: 609863], TCTN2 [OMIM: 613846], TCTN3 [OMIM: 613847], TMEM138 
[OMIM: 614459], TMEM216 [OMIM: 613277], TMEM231 [OMIM: 614949], TMEM237 [OMIM: 614423], 
TMEM67 [OMIM: 609884] , TTC21B [OMIM: 612014] and ZNF423 [OMIM: 604557].1-24; 47 In samples without 
causal variants, exome sequencing was performed as previously described 48 using Roche Nimblegen SeqCap 
EZ Human Exome Library v2.0 capture probes (36.5 Mb of coding exons) and paired-end 50 base pair reads 
on an Illumina HiSeq sequencer. In accordance with the Genome Analysis ToolKit’s (GATK) best practices, we 
mapped sequence reads to the human reference genome (hg19) using the Burrows-Wheeler Aligner (v.0.6.2), 
removed duplicate reads (PicardMarkDuplicates v1.70), and performed indel realignment (GATK 
IndelRealigner v.1.6) and base-quality recalibration (GATK TableRecalibration v1.6). We called variants using 
the GATK UnifiedGenotyper and flagged with VariantFiltration to mark potential false positives that did not 
pass the following filters: Heterozygous Allele Balance (ABHet) > 0.75, Quality by Depth > 5.0, Quality (QUAL) 
_ 50.0, Homopolymer Run (Hrun) < 4.0, and low depth (<6x). We used SeattleSeq for variant annotation  and 
the Combined Annotation Dependent Depletion (CADD) score to determine deleteriousness of identified 
missense variants.49 Based on CADD score data for causal variants in other JS-associated genes, we used a 
CADD score cutoff of 15 to define deleterious variants.47 
 
LR09-023 was ascertained as part of a larger study of genetic causes for Dandy-Walker malformation (DWM). 
Exome sequencing of this individual and his parents was performed by Beckman Coulter genomics as follows: 
genomic DNA isolated from peripheral blood was captured using the Agilent SureSelect V5 enrichment kit and 
sequenced on an Illumina HiSeq 2000 as 150-bp paired-end runs. Reads were aligned with BWA; variants 
were called with GATK and freebayes. Variants called by both GATK and freebayes were annotated using 
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Gemini,50 including data sets from the ExAc Exome,51 NHLBI 6500 Exome,52 and 1000 Genomes projects for 
variant frequencies, and amino-acid-change functional predictions from CADD scores.49 Variants were filtered 
for de novo, recessive (compound heterozygous or homozygous), or X-linked inheritance, <0.001 frequency in 
public databases, predicted to be deleterious by CADD >10, and expressed in human fetal (BrainSpan53) or 
adult (GTex54) cerebellum. 
 
For the two families in the Saudi Arabian cohort, DNA from the affected individuals, as well as their unaffected 
siblings and parents, were genotyped using the Axiom SNP Chip platform to determine the candidate 
autozygome.55; 56 The previously described “Mendeliome” targeted sequencing assay was then performed on 
DNA from affected members to search for likely causal variants in the known JS genes followed by whole 
exome sequencing in samples without causal variants.57 WES was performed using TruSeq Exome 
Enrichment kit (Illumina) following the manufacturer’s protocol. Samples were prepared as an Illumina 
sequencing library, and in the second step, the sequencing libraries were enriched for the desired target using 
the Illumina Exome Enrichment protocol. The captured libraries were sequenced using an Illumina HiSeq 2000 
Sequencer. The reads were mapped against UCSC hg19 by BWA. SNPs and Indels were detected by 
SAMTOOLS. Homozygous rare, predicted-deleterious, coding/splicing variants within the autozygome of the 
affected individual were considered as likely causal. We defined rare variants as those with frequency of 
<0.1% in publicly available variant databases (1000 Genomes, Exome Variant Server and gnomAD), as well 
as a database of 2,379 in-house ethnically-matched exomes, and deleterious if predicted to be pathogenic by 
PolyPhen, SIFT and CADD (score >15). 
 
Array CGH 
To assess copy number variation, we performed array comparative genomic hybridization using a custom 
8x60K oligonucleotide array (Agilent Technologies, Santa Clara, CA)58 targeting AHI1, ARL13B, ARMC9, 
B9D1, B9D2, C2CD3, C5orf42, CBY1 [OMIM: 607757], CC2D2A, CEP104 [OMIM: 616690], CEP120 [OMIM: 
613446], CEP290, CEP41 [OMIM: 610523], CEP83 [OMIM:615847], CSPP1, DDX59 [OMIM: 615464], EXOC8 
[OMIM: 615283], HYLS1 [OMIM:610693], IFT172, INPP5E, KCTD10 [OMIM: 613421], KIAA0556 [OMIM: 
616650], KIAA0586 [OMIM: 610178], KIAA0753 [OMIM: 617112], KIF7, MKS1, NPHP1, NPHP3 [OMIM: 
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608002], NPHP4 [OMIM: 607215], OFD1, PDE6D, PIBF1 [OMIM: 607532], POC1B [OMIM: 614784], 
RPGRIP1L, TBC1D32 [OMIM: 615867], TCTN1, TCTN2, TCTN3, TMEM107 [OMIM:616183], TMEM138, 
TMEM17 [OMIM: 614950], TMEM216, TMEM218, TMEM231, TMEM237, TMEM67, TTC21B, ZNF423. Probe 
spacing was a median of 11bp in the exons, and a median of 315bp throughout the intronic regions and 100kb 
on either side of each gene: Data were generated on an Agilent Technologies DNA Microarray Scanner with 
Surescan High-Resolution Technology using Agilent Scan Control software, and were processed and analyzed 
using Agilent Feature Extraction and Agilent Cytogenomics software. 
 
RNA isolation and quantitative PCR  
We cultured human fibroblasts from healthy controls in DMEM + 10 % fetal bovine serum (FBS) and 1% 
penicillin/streptomycin under standard conditions.59-61 To induce ciliogenesis, we cultured in DMEM without 
FBS once the cells reached ~70% confluency. After treatment with 0.05% trypsin, cycling cells and serum-
starved cells were harvested and RNA extracted using the Aurum Total RNA Mini Kit (Bio-rad, Hercules, CA). 
We generated cDNA from 2µg of total RNA using the iScript Reverse Transcription Supermix for RT-qPCR 
(Biorad, Hercules, CA). The expression of ARL13B and ARMC9 mRNAs was determined using qPCR. Each 
cDNA sample was amplified using Power SYBR Green PCR Master Mix (Applied Biosystems, Thermo Fisher 
Scientific) on the C1000 Thermal Cycler CFX (Bio-rad, Hercules, CA). After an initial denaturation of 10 
minutes at 95⁰C, each cycle (x39) consisted of denaturation at 95⁰C for 15 seconds and anneal/extend at 60⁰C 
for one minute with a plate read. The primers for ARL13B and ARMC9 are listed in Table S1. GAPDH was 
used as an endogenous control to normalize each sample. The experiment was performed in triplicate.  
 
Cell lines, antibodies and microscopy 
Human telomerase-immortalized retinal pigment epithelium (hTERT-RPE1) cells were grown in DMEM 
(PAA) supplemented with F12 in a 1:1 ratio with 10% fetal bovine serum and 1% penicillin/streptomycin. 
Cells were plated on glass cover slips for immunofluorescence imaging. Twenty-four hours after plating, 
cells were serum starved for 48 h in 0.2% FBS medium to induce cell cycle arrest and ciliogenesis. Cells 
were rinsed once with 1 x PBS at room temperature and then fixed in 2% paraformaldehyde for 20 min and 
permeabilized with 1% Triton-X for 5 min. Cells were blocked in freshly prepared 2% bovine serum albumin 
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for 45 minutes and then incubated with the following antibodies for 1 hour: rabbit anti-ARMC9 (Atlas 
Antibodies, HPA019041; 1:200), guinea pig anti-RPGRIP1L (SNC040, 1:300), and a monoclonal anti-
acetylated tubulin (clone 6-11-B1, Sigma-Aldrich, T6793; 1:1000) and goat anti-γ-tubulin (Santa Cruz 
Biotechnology, sc-7396, 1:250). Anti-ARMC9 recognizes an epitope at the N-terminal portion of the protein. 
Cells were stained with secondary antibodies for 45 min. The following secondary antibodies were used (all 
from Life Technologies/Thermo Fisher Scientific, Bleiswijk, The Netherlands; all diluted 1:500 in 2% BSA): 
anti-guinea pig IgG Alexa Fluor 647, anti-rabbit IgG Alexa Fluor 488, anti-goat IgG Alexa Fluor 647, and 
anti-mouse IgG Alexa Fluor 568. DAPI (4’,6-diamidino-2-phenylindole) stained the nucleus. Confocal 
imaging was done with the Zeiss LSM 880 Laser scanning microscope equipped with Airyscan technology. 
 
Antibody validation with siRNA knock down 
Reverse transfections on hTERT-RPE1 cells were performed with pre-designed Silencer Select siRNA to 
ARMC9 (Ambion from Life Technologies), as well as a positive control to knock down GAPDH (Ambion from 
Life Technologies) and a scrambled non-targeting negative control (Ambion from Life Technologies). 
Lyophilised siRNAs were re-constituted with RNase-free water (Thermo Scientific) to a final working 
concentration of 50 nM. Lipofectamine RNAiMax (LifeTechnologies) and Opti-MEM (LifeTechnologies) were 
used for siRNA transfection and done in accordance with the manufacturer’s protocol. Cells were harvested 
and lysed with RIPA lysis buffer supplemented with Complete Protease Inhibitor Cocktail Tablets (Roche) 72 
hours post transfection and western blotting was performed. Primary antibodies mouse monoclonal GAPDH 
(Thermo Scientific) and rabbit polyclonal ARMC9 (Human Protein Atlas Sigma Aldrich) were used at 1:1000 
and 1:500 dilutions respectively and incubated overnight at 4 degrees. Secondary antibodies goat anti-rabbit 
IRDye800 (LI-COR Biosciences) and goat anti-mouse IRDye680 (LI-COR Biosciences) were used at a dilution 
of 1:10,000 and incubated with blots for 1 hour at room temperature. Imaging was done with the Odyssey CLx 
imaging system (LI-COR Biosciences). Protein quantification was performed using Image Studio Lite software 
(LI-COR Biosciences). 
Zebrafish in situs, CRISPR, mutation assay, histology 
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Zebrafish were maintained at 28°C with a 14 h/10 h light/dark cycle as previously described.62 All zebrafish 
protocols were in compliance with internationally recognized guidelines for the use of zebrafish in biomedical 
research, and the experiments were approved by local authorities (Veterinäramt Zürich TV4206).  
 
In situ hybridization was performed following standard protocols with a probe spanning over 800 bp at the 3’ 
end of armc9 generated using the primers 5’-AGCTCAACTCAGCGACCATC-3’ and 3’-
TGCTGTTACAGGAAGCTGGA-5’. sgRNAs for CRISPR/Cas9 mutagenesis were designed using the 
CHOPCHOP website: 3’-GGGATTGGGCACAAATGGCA-5’ and 3’-GGAACAGCTCCTGAAAGGAC-5’ for exon 
4 and 5’-GGTCAAAGAGCTGAATGACT-3’ and 3’-GGAGCTCCGTCAGGACTTTC-5’ for exon 14/15. Pairs of 
sgRNAs for each target site were mixed with Cas9 protein (gift from Darren Gilmour) and injected into 1-cell 
stage embryos obtained through natural matings. Individual larvae were lysed for assessment of mutagenesis 
efficiency. Amplification of the target regions for genotyping was performed using primer pairs 5‘-
CAGCCAAACCACTGAGTTCC-3‘ and 3‘-TGACCCTGTAGTGTGTGCGTA-5‘ for exon 4 and 5’-
CACGCCTTGCACCACACT-3’ and 3‘-CACTCCCCTGTTTGAGCAAT-5‘ for exons 14/15. The PCR products 
were analyzed on gel electrophoresis, bands were cut out and subcloned before sequencing. The remaining 
F0 fish were raised. Brains of four F0 fish with curved bodies were dissected out at five months of age, halved 
and fixed in 2.5% Glutaraldehyde in 0.1M Cacodylate buffer and prepared for scanning electron microscopy 
(SEM) following standard protocols. SEM was performed on a ZEISS Supra VP 50 microscope. Cryosections 
were performed following standard protocols and IHC was performed as previously described,37; 62 using the 
zpr1 antibody.63 Vybrant® DiO (ThermoFisherScientific) and DAPI were used for counterstaining. Images were 
acquired on a Leica HCS LSI confocal microscope. Histological sections using Technovit were performed as 
previously described.62 Images were acquired on an Olympus BX61 microscope.  
 
RESULTS 
Exome sequencing reveals ARMC9 mutations as a cause for JS 
To identify novel genetic causes of JS, we performed whole exome sequencing on a cohort of 53 
individuals (51 families) with a clinical diagnosis of JS enrolled in the University of Washington (UW) Joubert 
Syndrome Research Program. Inclusion criteria comprised the presence of clinical findings of JS 
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(developmental delays, hypotonia, ataxia, and/or oculomotor apraxia), diagnostic brain imaging findings, and 
lack of mutations in 28 JS-associated genes (NPHP1, AHI1, CEP290, RPGRIP1L, TMEM67, CC2D2A, 
ARL13B, INPP5E, OFD1, TMEM216, CEP41, TMEM237, TCTN2, KIF7, TCTN1, TMEM138, MKS1, 
C5ORF42, TMEM231, TCTN3, CSPP1, PDE6D, IFT172, ZNF423, TTC21B, B9D1, B9D2, and C2CD3) based 
on targeted sequencing.46; 47 Variants from the exome sequencing data that were rare (minor allele frequency 
<1% in the exome variant server [EVS] database) and predicted to be deleterious (stop-gain, frameshift, 
canonical splice variants and variants with CADD score >15) were retained for further analysis. 
We identified pairs of siblings in two families that shared two rare, predicted-deleterious variants (RDVs) in 
ARMC9 (NM_025139.4): UW132-3 and -4 carry c.205G>A, p.Gly69Arg and c.1336C>T, Arg446Cys, while 
UW335-3 and -4 carry c.259C>T, p.Arg87* and c.1027C>A, p.Arg343Ser (Table 1 and Figure 1). 
We then performed targeted sequencing of ARMC9 using the Molecular Inversion Probe (MIPs) capture 
method followed by next generation sequencing on samples from 534 individuals in 456 families with and 
without known causes. Three additional individuals in three families have ARMC9 RDVs: UW348-3 has a 
homozygous c.51+5G>T, predicted splice variant, UW349-3 has two RDVs (predicted splice c.1474+1G>C 
and missense c.1027C>T, p.Arg343Cys), while UW116-3 has a single heterozygous c.1027C>T, p.Arg343Cys. 
Based on decreased sequence coverage for two consecutive MIPs covering exon 14 in UW116-3, we 
suspected a deletion in UW116-3. We performed comparative genomic hybridization using a custom array 
targeting the JS genes,58; 64; 65 and identified a 2.5kb deletion encompassing exon 14 in UW116-3 (Figure 1B-
D). Exon 14 is 124 basepairs long, so its loss is predicted to result in a frameshift and truncation of the protein, 
or nonsense mediated decay of the transcript. 
In parallel, exome sequencing in two other cohorts identified biallelic RDVs in ARMC9: three individuals 
(SA1-3, SA2-3 and -4) from two families in a cohort of 47 Saudi Arabian families66 affected by JS had 
homozygous ARMC9 missense RDVs (c.1027C>T, p.Arg343Cys and c.1559C>T, p.Pro520Leu), and a single 
individual with JS (LR09-023) from a mixed cohort of 100 individuals with Dandy-Walker malformation and 
cerebellar hypoplasia had compound heterozygous ARMC9 RDVs (c.1474G>A, p.Gly492Arg and c.1027C>T, 
p.Arg343Cys). In total, we identified 10 different ARMC9 RDVs (1 stop-gain, 2 splice, 6 missense, and 1 single 
exon deletion) in 11 individuals from 8 families. All variants were validated by Sanger sequencing, and for 
seven individuals from five families their segregation with the disease was confirmed in parents and siblings; 
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segregation was not performed in the remaining four families because DNA was not available from parents 
(Table 1). c.1027C>T, p.Arg343Cys appears to be a recurrent mutation rather than a founder variant, since it is 
present in families of diverse ethnicities, and a second variant (c.1027C>A, p.Arg343Ser) affects the same 
position. ARMC9 is predicted to have a Lissencephaly type-1-like homology (LisH) motif, a coiled-coil domain, 
and armadillo repeats (Figure 1A). Two of the missense RDVs are in the armadillo repeats, while the other four 
missense RDVs are not located in known domains. 
 
ARMC9-related JS is indistinguishable from JS due to other genetic causes 
All of the affected individuals have typical features of JS including hypotonia and developmental disability, 
most severely affecting motor and speech function (Table 1). Ages range from 2 to 33 years. Most of the 
individuals have isolated neurodevelopmental issues, including two with seizures (UW132-3 and UW116-3). 
Two individuals (UW132-4 and SA2-3) have postaxial polydactyly, while SA2-3 also has syndactyly. Two 
individuals (UW348-3 and SA2-3) also have retinal dystrophy, but none have kidney or liver involvement. 
UW349-3 has a more complex presentation with hypopituitarism, bilateral optic nerve hypoplasia, bifid uvula, 
and an abnormal brainstem (see below). 
Based on direct review of the brain MRIs, all of the affected individuals have the “molar tooth sign,” as well 
as dysplasia of the superior cerebellar folia (Figure 2A-B, F and Table S2). Three individuals (UW335-4, LR09-
023, and SA2-3) have cerebellar hemisphere dysplasia, seen in up to 1/3 of individuals with JS (Figure 2C).67 
In addition to the MTS, LR09-023 has a large posterior fossa with a rotated cerebellar vermis consistent with 
Dandy-Walker malformation, (Figure 2D-E, I). LR09-023 also has a single periventricular heterotopia (Figure 
2D), as do UW116-3 and UW335-4. The two oldest individuals (UW132-3 and -4) have an atrophic appearance 
to their cerebellum, more severely affecting the vermis than the hemispheres (Figure 2G). UW349-3 has a 
kinked brainstem and cervicomedullary junction heterotopia (Figure 2H) seen in a small subset of individuals 
with JS,67-71 and UW349-3 and SA2-3 have an absent posterior pituitary bright spot, but only UW349-3 has 
known pituitary insufficiency. 
 
ARMC9 localizes to the basal bodies of primary cilia 
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JS-associated proteins have been shown to localize in and around primary cilia;40; 45; 72-74 therefore, we 
used a commercially available ARMC9 antibody to evaluate endogenous ARMC9 localization in ciliated 
hTERT-RPE1 cells. ARMC9 co-localized with γ-tubulin at the base of cilia (Figure 3A). To get enhanced details 
of ARMC9 localization, we turned to superresolution imaging.  ARMC9 localized to the ciliary basal body 
(Figure 3B, white arrowhead), basal to but not overlapping with the transition zone marker RPGRIP1L, as well 
as to the daughter centriole (Figure 3B, white arrow) marked by acetylated α-tubulin antibody (Figure 3B).  
 
ARMC9 expression is upregulated in ciliated cells 
Based on data from model systems and humans, many genes involved in cilium function are upregulated 
in ciliated cells.75-79 We evaluated ARMC9 expression by quantitative PCR in control human fibroblasts with 
and without serum in the medium. In the presence of serum, fibroblasts actively divide and few have cilia, but 
in response to serum starvation, 80-90% drop out of the cell cycle and make cilia, similar to other published 
results.80 ARMC9 expression was 1.9- to 3.6-fold higher in serum-starved cells than cells grown with serum 
(Figure 3C). For comparison, expression of another JS-associated gene, ARL13B, was 2.4-fold higher in 
serum-starved cells. 
 
Zebrafish armc9 mutants display typical ciliopathy phenotypes 
To investigate the function of ARMC9 in vivo, we turned to the zebrafish model. Zebrafish have a single 
ARMC9 orthologue that has 58% identity and 72% similarity with the human protein. Based on database 
predictions and manual curation, both the LisH domain and the armadillo-fold domain are conserved in 
zebrafish at similar positions to the human protein (amino acids 7-39 and 375-600 respectively) (Supp Figure 
1). In adult zebrafish, armc9 is expressed in multiple CNS regions based on in situ hybridization, including the 
cerebellum (Supp Figure 1), all periventricular regions (Figure 4A) and all layers of the retina (Figure 4B). To 
explore whether loss of armc9 function results in ciliopathy phenotypes, we engineered frameshift mutations in 
zebrafish using CRISPR/Cas9 (Supp Figure 2). Co-injecting pairs of small guide RNAs targeting either exon 4 
or exons 14-15 (the latter corresponding to the middle of the armadillo-fold domain), we generated mutations 
with very high efficiency (91% of sequenced clones from individual F0 larvae carried indels, the majority of 
which were out-of-frame; Supp Figure 2). Of approximately 140 surviving F0 fish raised, 10 developed a 
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curved body axis around six weeks of age (Figure 4C-D), including both exon 4 and exon 14-15 targeted 
animals. The body curvature phenotype correlated well with the presence of indels affecting the targeted 
exons; genotyping of 49 F0 fish by gel electrophoresis demonstrated various armc9 indels in 11 fish, only one 
of which did not have a curved body shape. Moreover, such body curvature was never observed in hundreds 
of raised F0 fish injected with sgRNA targeting non-ciliary genes (20 different sgRNAs). A recent study 
suggested body curvature in zebrafish is caused by deficient ependymal cilia-generated cerebrospinal fluid 
(CSF) flow.81 Indeed, using SEM we observed a substantial reduction of cilia numbers on the ventricular 
surface of adult zebrafish harboring armc9 mutations (Figure 4E-F). In addition, a subset of F0 fish with body 
curvature also displayed a retinal coloboma and had shortened photoreceptor outer segments, typical 
phenotypes observed with ciliary dysfunction (Figure 4G-J and Supp Figure 2).38 Taken together, these results 
confirm that armc9 loss-of-function in zebrafish causes typical ciliopathy phenotypes and strongly support a 
role for armc9 in ciliary function. 
 
DISCUSSION 
Mutations in more than 35 genes have been identified in individuals with JS, explaining the genetic cause 
in 62% to 97% of cases, depending on the study.47; 66; 82 In addition to these known causes, we now identify 
ARMC9 mutations as an additional cause of JS accounting for almost 1% of families in our cohort of >500. 
Substantial functional evidence supports ARMC9 as a ciliopathy-associated gene. 
 
ARMC9 localizes to the basal body 
We provide evidence that ARMC9 localizes to the ciliary basal body, similar to other JS-associated 
proteins (Figure 3A-B). The basal body originates from the mother centriole that docks at the cell membrane 
during interphase to nucleate the ciliary axoneme. The daughter centriole remains tethered to the basal body 
by an interconnecting fiber, and both structures often appear as juxtaposed puncta on immunofluorescence 
images. Basal bodies are composed of nine short triplet microtubules arranged in a circle, and two of the three 
microtubules in each basal body triplet extend as axonemal microtubules. Several other JS-associated 
proteins, OFD1, KIAA0586, and C2CD3, also localize to the basal body.40; 45; 72-74; 83 Strikingly, ARMC9 and 
OFD1 both have an N-terminal LisH motif that is known to bind to microtubules (Figure 1A).72; 84; 85 Two 
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published proteomic studies in murine inner medullary collecting duct (IMCD3) cells also provide support for 
ARMC9 as a cilium-associated protein: 1) ARMC9 was detected a total of 31 times across ciliary fractions via 
MudPIT mass spectrometry of isolated cilia;86 2) Proximity labeling using a promiscuous biotinylating enzyme 
conjugated to the transition zone protein NPHP3 detected ARMC9-specific peptides (6 spectral counts), thus 
providing direct evidence for their adjacency.87 
 
ARMC9 is present in ciliated organisms and upregulated in ciliated cells 
The use of comparative genomics to compile genes exclusively present in ciliated organisms versus non-
ciliated organisms is a common technique in identifying ciliary genes.88; 89 ARMC9 homologs are present in 
ciliated eukaryotes from humans to unicellular flagellates such as Trochaic trifallax, but absent in plants, fungi, 
bacteria, viruses, and Archaea.90 Expression of the ARMC9 C. elegans homolog, F59G1.4, is restricted to 
sensory neurons, the only ciliated cells in this organism.91-93 Ciliary gene induction was first linked to 
ciliogenesis in classical experiments in unicellular flagellates, notably Chlamydomonas, a model system 
particularly well-suited to study ciliary biology. These experiments demonstrated that new protein synthesis 
was required for full cilia regeneration via use of protein synthesis inhibitors or enucleating cells.75; 76 Later 
experiments show that ciliary genes are widely induced during ciliogenesis and maintained at high levels in 
ciliated cells.77-79 Ciliary genes are similarly upregulated in higher organisms.36; 94; 95 Similar to other ciliary 
genes, we demonstrate that ARMC9 expression is upregulated in human ciliated fibroblasts, as compared to 
cycling cells (Figure 3C). 
 
 Zebrafish harboring armc9 mutations display typical ciliopathy phenotypes 
In a vertebrate model, zebrafish harboring CRISPR-engineered armc9 mutations display phenotypes 
similar to those seen with loss-of-function for zebrafish orthologs of other ciliopathy-associated genes (Figure 
4).38; 96; 97 The retinal dystrophy and/or curved body axis are also seen in loss-of-function models for the 
cc2d2a, ahi1, and ift genes.38; 97-100 Furthermore, we show a strong reduction of cilia  in the brain ventricles of 
zebrafish harboring armc9 mutations, suggesting the gene product may participate in early stages of 
ciliogenesis or be required for ciliary maintenance. The mosaic state of the animals analyzed in this work does 
not allow for discrimination between these two possibilities. Indeed, the presence of residual cilia on some 
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ventricular cells may be explained by lack of armc9 mutations in those cells, or  incomplete penetrance of the 
phenotype. Future analysis of stable lines will help address these possibilities. The identical phenotypes 
observed in multiple animals generated using guides targeting different armc9 regions, combined with lack of 
these phenotypes with CRISPR/Cas9-generated deletions in 20 different non-ciliary genes, strongly support 
the specificity of the observed phenotypes and argue against non-specific or off-target effects of 
CRISPR/Cas9. 
 
In conclusion, we demonstrate that mutations in ARMC9 cause JS and show that ARMC9 localizes to the 
basal body. Given the LisH domain, ARMC9 likely binds microtubules there, but the details of its function 
remain to be elucidated. Delineating all of the genes involved in JS will enable future work to determine how 
proteins that localize to the basal body, transition zone, cilium proper, and cilium tip all contribute to the 
molecular mechanism(s) underlying JS. Understanding the molecular mechanisms of JS will lead to more 
specific treatments in the future and further our understanding of basic ciliary biology in health and disease. 
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Figures 
 
 
Figure 1. ARMC9 mutations cause JS:  (A) The ARMC9 gene encodes a protein with an N-terminal LisH 
domain (green square), a coiled coil domain (yellow polygon), and a series of armadillo repeats (blue oval). 
Patient mutations are indicated by red arrows. (B-D) Confirmation of ARMC9 exon 14 deletion in UW116-3. No 
difference in the size or number of PCR products is observed between cDNA isolated from UW116-3 and two 
unaffected control cell lines using primers in exons  9 and 14 (C-D). Primers in exons 13 and 17 amplify a full-
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length product and a shorter product (bracket) in UW116-3, but only the full-length product in the two control 
lines. Sequencing genomic DNA amplified by primers flanking exon 14 reveals a 2516bp deletion with a 22bp 
insertion (D). 
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Figure 2. Brain imaging findings in individuals with ARMC9-related Joubert syndrome. (A-C) MTS (A), 
inferior cerebellar dysplasia (white arrows in B), and superior cerebellar dysplasia (white arrow in C) in SA2-3. 
(D-E) MTS (D), posterior fossa cyst (asterisks in D-E), and ventriculomegaly (plus signs in E) in LR09-023. 
Note the single periventricular nodular heterotopia (black arrowhead in D). (F) Vermis hypoplasia and elevated 
roof of the 4th ventricle in SA2-3 (white arrow). (G) Cerebellar vermis hypoplasia and atrophy in UW132-3 
(white arrow). (H) Kinked brainstem and cervicomedullary heterotopia in UW349-3 (white arrowhead). (I) 
Enlarged posterior fossa fluid collection (white asterisk) and rotated vermis (white arrowhead) in LR09-032. (A-
E) are axial T2-weighted images; (F-I) are sagittal T1-weighted images. 
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Figure 3. ARMC9 localization and ARMC9 expression in ciliated and proliferating cells  
(A) ARMC9 (green) co-localizes with γ-tubulin (white) at the basal body of the primary cilium in serum-starved 
hTERT RPE1 cells via standard fluorescence microscopy. Anti-acetylated α-tubulin (red) marks the ciliary 
axoneme. DAPI (blue) stains the nuclei. (B) Superresolution imaging reveals ARMC9 (green) localizes at the 
basal body (white arrowhead) and at the daughter centriole (white arrow) of the primary cilium in serum-
starved hTERT RPE1 cells. The ciliary marker anti-RPGRIP1L (white), marks the ciliary transition zone and 
anti-acetylated α-tubulin (red) marks the ciliary axoneme. DAPI (blue) stains the nuclei. (C) ARMC9 expression 
in control human fibroblasts grown with serum (proliferating cells) and without serum (ciliated cells), assessed 
20 
 
using qPCR with GAPDH as a reference gene. ARL13B is used a positive control for a gene upregulated in 
ciliated cells. 
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Figure 4: armc9 loss-of-function in zebrafish leads to typical ciliopathy phenotypes 
(A-B) Expression of armc9 in zebrafish adult brain (A) and retina (B) by in situ hybridization. Note the 
expression along ventricular surfaces in (A) and in all retinal layers, including the photoreceptor (PR) and the 
inner nuclear layer (INL) in (B-B’). (C-D) Adult zebrafish harboring armc9 mutations display a curved body 
shape (D) compared to wild-type controls (C). (E-F) Scanning electron microscopy image of the ventricular 
22 
 
surface demonstrates bundles of cilia in wild-type (E) but substantial reduction of cilia numbers in F0 armc9 
fish (F). (G-H) Histological sections through adult zebrafish eyes of wild-type (G) and F0 armc9 mutants (H) 
showing a coloboma (arrow). (I-J) Higher magnification images show the different retinal layers in wild-type fish 
(I) including the PRs and their long outer segments (OS, bracket) which represent highly specialized ciliary 
compartments. (J) Note the shortened OS in F0 armc9 mutants (bracket). Scale bars are 200 µm in (A-B), 50 
µm in (B’), 5 mm in (C-D), 3 µm in (E-F), 250 µm in (G-H) and 50 µm in (I-J). v ventricle, PGZ periventricular 
grey zone of optic tectum, Hv ventral zone of periventricular hypothalamus, PR photoreceptors, INL inner 
nuclear layer. 
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Table 1. Phenotypic features of individuals with ARMC9-related Joubert syndrome with mutations 
 
ID# UW132-3 UW132-4 UW348-3 UW116-3 UW335-3 UW335-4 UW349-3 LR09-023 SA1-3 SA2-3 SA2-4 
Gene ARMC9 ARMC9 ARMC9 ARMC9 ARMC9 ARMC9 ARMC9 ARMC9 ARMC9 ARMC9 ARMC9 
Mutation 1 c.205G>A p.Gly69Arg 
c.205G>A 
p.Gly69Arg 
c.51+5G>T 
splice 
 
c.1027C>T 
p.Arg343Cys 
 
c.259C>T 
p.Arg87* 
c.259C>T 
p.Arg87* 
c.1474+1G>C 
splice 
c.1474G>A 
p.Gly492Arg 
c.1027C>T 
p.Arg343Cys 
c.1559C>T 
p.Pro520Le
u 
c.1559C>
T 
p.Pro520L
eu 
MAF 0.000025 (7/277212) 
0.000025 
(7/277212) ND ND 
0.000018 
(5/277214) 
0.000018 
(5/277214) ND ND 
0.000053 
(13/246244) 
0.0000041 
(1/246192) 
0.0000041 
(1/246192) 
CADD v1.3 33 33 14.54 N/A 35 35 23.5 26 34 34 34 
parent paternal paternal unable maternal paternal paternal maternal maternal maternal maternal maternal 
Mutation 2 
c.1336C>T 
p.Arg446Cy
s 
c.1336C>T 
p.Arg446Cy
s 
c.51+5G>T 
splice 
c.1211_1334
del 
p.Arg405Afs*
7 
c.1027C>A 
p.Arg343Ser 
c.1027C>A 
p.Arg343Se
r 
c.1027C>T 
p.Arg343Cys 
c.1027C>T 
p.Arg343Cys 
c.1027C>T  
p.Arg343Cys 
c.1559C>T 
p.Pro520Le
u 
c.1559C>
T 
p.Pro520L
eu 
AF 0.0000041 (1/246076) 
0.0000041 
(1/246076) ND 
0.000053 
(13/246244) 
0.0000041 
(1/246244) 
0.0000041 
(1/246244) 0.000053 (13/246244) 
0.000053 
(13/246244) 
0.000053 
(13/246244) 
0.0000041 
(1/246192) 
0.0000041 
(1/246192) 
CADD v1.3 34 34 14.54 34 34 34 34 34 34 34 34 
parent maternal maternal unable paternal maternal maternal paternal paternal paternal paternal paternal 
Ethnicity/ 
country 
white/ 
US 
white/ 
US 
white/ 
Israel 
white/ 
US 
white/ 
Australia 
white/ 
Australia 
>1 race/ 
US 
white/ 
US 
Arab/ 
Saudi 
Arab/ 
Saudi 
Arab/ 
Saudi 
gender F M F F F M M M M F M 
age (years) 33 29 10 8 5 7 2 8 7 4 5 
Dev Disability Y Y Y Y Y Y Y Y Y Y Y 
apnea/tachyp N N unk both both N A T Y* N Y* 
abnl eye mvts Y Y Y Y Y Y Y unk Y Y N 
retinal 
dystrophy N N Y N N N N unk unk Y N 
kidney N N unk unk N N N unk N N N 
liver N N unk unk N N N unk N N N 
polydactyly N Y unk N N N N N N Y N 
coloboma N N unk N N N N unk unk N N 
ptosis N Y unk Y N N Y Y Y Y Y 
seizures Y N N Y N N N N N N N 
other 
Hysterecto
my 2016 
(heavy 
bleeding); 
worsening 
visual 
acuity; 
seizures 
Lithium 
induced 
hypo-
thyroidism L 
foot 
postaxial 
polydactyly 
Abnormal 
ERG 
G-tube - single 
heterotopia 
(left 
occipital 
horn) 
Micrognathia; high 
palate; bifid uvula; 
bilateral optic nerve 
hypoplasia, GH 
deficiency; 
micropenis, eyelid 
implants; possible 
hearing loss; 
borderline HSM;  
Dandy Walker 
malformation; 
Ventriculo- and 
cysto-peritoneal 
shunts; non-
ambulatory; 
non- verbal at 
age 8 yr 
- Broad nasal 
bridge, thin 
upper lip, Y-
shaped 2/3 
toe 
syndactyly 
- 
A=apnea, AF= Allele Frequency based on gnomAD,51 F=female, GH=Growth Hormone, HSM= heptosplenomegaly, ID=Identification, M=male, N=No, ND=not 
documented, T=tachypnea, unk=unknown, Y=Yes; *=transient neonatal
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Supplementary Data 
  
Figure S1: zebrafish armc9 gene structure and expression  
(A) Schematic representation of the zebrafish armc9 gene (with exonic/intronic structure) and 
protein below, showing the predicted LisH domain (green, N-terminal) and the armadillo-type-
fold (ATF) domain (blue). (B-K) In situ hybridization on brain cryosections from adult zebrafish 
(B-F transverse sections, G-K sagittal sections). (B) Note staining along the ventricles marked 
with the arrows. (C-E) Higher magnification views of the boxed areas in (B). (C) Ventral zone of 
periventricular hypothalamus Hv, (D) periventricular grey zone of optic tectum PGZ, (E) lateral 
division of valvula cerebelli Val and torus longitudinalis TL. (F) Absence of staining with the 
control sense probe. (G) Sagittal section through the brain and eye, showing signal in the 
cerebellum (boxed area H), the hypothalamus (boxed area I) and the optic tectum (boxed area 
J). CCe corpus cerebelli, LCa lobus caudalis cerebelli, H periventricular hypothalamus, PGZ 
periventricular grey zone of optic tectum, TL torus longitudinalis. (K) Absence of staining with 
the control sense probe. Scale bars: 200μm (B,F,G,K), 50μm (C-E), 100 μm (H-J).  
 

Fig S2: CRISPR/Cas9 armc9 mutants  
(A) Representative gel showing PCR amplification around the CRISPR target sites on finclips 
from adult F0 animals with body curvature. Note the presence of bands in addition to the WT-
sized band in the curved fish. The PCR product from animal #2 was cloned and sequenced, 
revealing that 9 of 9 selected clones had small out-of-frame indels, indicating that this animal 
had a very high rate of mutations in armc9 despite a wild-type-sized band on the gel. (B-C) 
Scanning electron microscopy (SEM) overview images of dissected and halved brains from F0 
armc9 animals with body curvature. The arrow points to the ventricular surfaces shown in (D-E). 
(D-E) Close up SEM images of the ventricular surface showing bundles of cilia in wild-type 
animals (D). In contrast, armc9 F0 mutant animals display a paucity of cilia (E). (F-I’) 
Immunohistochemistry on cryosections through whole eyes of wild-type (F) and an F0 armc9 
mutant (G-I’) stained with the zpr1 antibody marking red-green cone cell bodies (red in F-I) and 
DiO highlighting photoreceptor (PR) outer segments (OS) (green in H-I). Note the thinner retinal 
layers and the coloboma (arrows in G and boxed area in H). (I-I’’) represent the boxed area in 
(H). Note the discontinuity of the retinal layers and the presence of a second leaflet of retina 
folding back, with presence of PRs and OSs in a mirror image on either side of this aberrant 
second retinal layer (arrows). Scale bars are 100μm in (B-C), 3μm in (D-E), 100μm in (F-H), 
50μm in (I’-I’’). 
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 Fig S3: ARMC9 antibody validation  
(A) Western blot analysis of hTERT-RPE cells transfected with non-targeting control siRNA and 
siARMC9. Cell lysates were probed with antibodies to ARMC9 and GAPDH as loading control. 
(B) Quantification of western blot signal in (A) quantified via densitometry normalized to 
GAPDH.  
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Table S1.  Oligonucleotide primers for qPCR  
Target Gene Primer ID Sequence (5'-3') 
ARL13B Exons 2/3 Forward:       AATGCTGGTAAAACCGCAAC 
 Reverse:        TTCCCCGAATTCTTATTCCA 
ARMC9 Exons 21/22 Forward:       GGAGTGACCACCAGGGAATG  
 Reverse:        GGCCACACGAAGAGAACAGA 
ARMC9 Exons 3/4 Forward:       GAGACCGGACAAAGAGGAGC 
 Reverse:        CTCTGTGGTCTGGCTCAAGG 
ARMC9 Exons 2/3 Forward:       TTCCATCCGAGATGGGGACT 
 Reverse:        GCTCCTCTTTGTCCGGTCTC 
GAPDH Exons 2/6 Forward:       AGGTGAAGGTCGGAGTCAAC 
  
TTCACACCCATGACGAACAT 
 
 
  
 
Table S2. Brain imaging findings in individuals with ARMC9-related Joubert syndrome 
UW# UW132-3 UW132-4 UW348-3 UW116-3 UW335-3 UW335-4 UW349-3 LR09-023 SA1-3 SA2-3 SA2-4 
Age at MRI 29 yr 18 yr 10 mo 6 mo 2 mo 16 mo 7 mo 1 mo 14 mo 2 yr 4 yr 
Molar Tooth Sign Y Y Y Y Y Y Y Y Y Y Y 
Agenesis of the corpus 
callosum N N N N N N N N N N N 
Ventriculomegaly N N mild mild N N N N mild N N 
PMG N N N N N N N N N N N 
Heterotopia N N N Y N Y N Y N N N 
Pituitary bright spot P P P P P P A P A P P 
Superior cb dysplasia Y Y Y Y Y Y Y Y Y Y Y 
cb hemisphere dysplasia N N N N N Y N Y N Y N 
cb atrophy Y Y N N N N N N N N N 
cervicomedulary 
heterotopia N N unk N N N Y possible N N N 
Foramen magnum 
cephalcele unk N N N N N Y possible Y N N   
moderate-
size retro-cb 
fluid 
 
single L 
occipital 
PVNH 
 
single L 
occipital PVNH 
kinked 
brainstem 
large posterior 
fossa with retro-cb 
fluid, single L 
temporal PVNH 
  
thick 
corpus 
callosum 
 
 
A=Absent, cb=cerebellar, L=Left, mo=months, N=No, P=Present, PMG=PolyMicroGyria, PVNH=PeriVentricular Nodular Heterotopia, unk=unknown, 
Y=Yes, yr=years, 
 
 
 
